Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$321,033
-$21,651 QoQ
Shares Held
11,364
-8.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OCCUDO QUANTITATIVE STRATEGIES LP holds $11,453,802 across 11 Biotechnology names. PHVS ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
121,800 | $5,842,746 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
13,826 | $2,336,870 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,669 | $1,730,530 | |
| 4 | NKTR |
Nektar Therapeutics
|
8,948 | $643,808 | |
| 5 | PHVS |
Pharvaris N.V.
This page
|
11,364 | $321,033 | |
| 6 | ALMS |
Alumis Inc.
|
11,124 | $245,061 | |
| 7 | ACET |
Adicet Bio, Inc.
|
15,100 | $102,831 | |
| 8 | COYA |
Coya Therapeutics, Inc.
|
23,642 | $93,149 |
All Filings in PHVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,033 | 11,364 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $342,684 | 12,349 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||